Dilemmas in Elderly Diabetes and Clinical Practice Involving Traditional Chinese Medicine

Author:

Xue Chongxiang12ORCID,Chen Ying13ORCID,Bi Yuntian4,Yang Xiaofei1ORCID,Chen Keyu2,Tang Cheng5,Tong Xiaolin25,Zhao Linhua2,Wang Han6

Affiliation:

1. Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China

2. Institute of Metabolic Diseases, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China

3. Department of Integrative Cardiology, China-Japan Friendship Hospital, Beijing 100029, China

4. School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha 410208, China

5. National Key Laboratory of Efficacy and Mechanism on Chinese Medicine for Metabolic Diseases, Beijing University of Chinese Medicine, Beijing 100029, China

6. School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China

Abstract

Diabetes is a widespread chronic disease that occurs mainly in the elderly population. Due to the difference in pathophysiology between elderly and young patients, the current clinical practice to treat elderly patients with anti-diabetes medications still faces some challenges and dilemmas, such as the urgent need for early diagnosis and prevention, and an imbalance between restricted dietary intake and the risk of undernutrition. Traditional Chinese medicine (TCM) offers various treatment regimens that are actively utilized in the field of diabetes management. Through multiple targets and multiple pathways, TCM formulas, medicinal herbs, and active natural products enhance the efficacy of diabetes prevention and diabetes control measures, simplify complex medication management, and improve common symptoms and common diabetic complications in elderly people. Historically, natural products have played a key role in material composition analysis of TCM and mechanism interpretation to enable drug discovery. However, there have been few conclusions on this topic. This review summarizes the development of TCM for the prevention and management of diabetes in elderly people, existing evidence-based clinical practices, and prospects for future development.

Funder

National Natural Science Foundation of China

High Level Chinese Medical Hospital Promotion Project

Scientific Research Funds for HuTian Visiting Professors at Beijing University of Chinese Medicine

Publisher

MDPI AG

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3